{
    "Trade/Device Name(s)": [
        "Access\u00ae EPO Assay",
        "Access EPO Calibrators"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K052223",
    "Predicate Device Reference 510(k) Number(s)": [
        "K936016",
        "K983203",
        "K980737",
        "K992799"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGT",
        "JIT"
    ],
    "Summary Letter Date": "October 6, 2006",
    "Summary Letter Received Date": "August 31, 2006",
    "Submission Date": "August 30, 2006",
    "Regulation Number(s)": [
        "21CFR864.7250"
    ],
    "Regulation Name(s)": [
        "Erythropoietin Assay"
    ],
    "Analyte Class(es)": [
        "hematology",
        "endocrine"
    ],
    "Analyte(s)": [
        "Erythropoietin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (heparin)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Access Immunoassay Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent immunoassay",
        "Paramagnetic particle-based immunoassay"
    ],
    "Methodologies": [
        "Immunometric (sandwich) assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Access\u00ae EPO Assay and Calibrators measuring erythropoietin in serum and plasma using chemiluminescent immunoassay on Access Immunoassay Systems",
    "Indications for Use Summary": "Quantitative determination of erythropoietin levels in human serum and plasma to aid in diagnosis of anemias and polycythemias and in prediction and monitoring of response to recombinant erythropoietin therapy",
    "fda_folder": "Hematology"
}